Literature DB >> 8561965

The effect on methamphetamine on the mRNA level for 14.3.3 eta chain in the human cultured cells.

T Muratake1, S Hayashi, Y Ichimura, K Morii, R Kuwano, T Ichikawa, T Kumanishi, T Isobe, M Watanabe, H Kondo.   

Abstract

14.3.3 protein, a brain-specific protein, is an activator of tyrosine and tryptophan hydroxylases, key enzymes for biosynthesis of dopamine and serotonin. In this article, we describe cloning of cDNA for human brain 14.3.3 eta chain and expression of 14.3.3 eta chain mRNA in some human cultured cells. The cloned cDNA is 1730 bp long and contains 191 bp of a 5'-noncoding region, the complete 738 bp of coding region, and 801 bp of a 3'-noncoding region, containing three polyadenylation signals. This cDNA encoded a polypeptide of 246 amino acids (M(r) 28,196). Furthermore, using in situ hybridization histochemistry, the expression of mRNA for this protein was examined in the rat central nervous system. In situ hybridization histochemistry indicated that 14.3.3 eta chain mRNA is detected not only in the monoamine-synthetic neurons, but also in other neurons in the discrete nuclei, which synthesize neither cathecholamine nor serotonin. Northern blot analysis demonstrated that the addition of methamphetamine into the cultured medium increased the mRNA level for 14.3.3 eta chain in U-251 cells, but did not increase that of GFAP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8561965     DOI: 10.1007/bf02740697

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  16 in total

1.  Brain hexokinase activity. Investigation of brain tissue from rats receiving methamphetamine hydrochloride (Methedrine) and from schizophrenics.

Authors:  Y TAKAHASHI; Y AKABANE
Journal:  Arch Gen Psychiatry       Date:  1960-12

2.  Establishment of a human oligodendroglial cell line.

Authors:  E Miyake
Journal:  Acta Neuropathol       Date:  1979-04-12       Impact factor: 17.088

3.  Molecular cloning of cDNA to rat 14-3-3 eta chain polypeptide and the neuronal expression of the mRNA in the central nervous system.

Authors:  M Watanabe; T Isobe; T Okuyama; T Ichimura; R Kuwano; Y Takahashi; H Kondo
Journal:  Brain Res Mol Brain Res       Date:  1991-05

4.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Distinct forms of the protein kinase-dependent activator of tyrosine and tryptophan hydroxylases.

Authors:  T Isobe; T Ichimura; T Sunaya; T Okuyama; N Takahashi; R Kuwano; Y Takahashi
Journal:  J Mol Biol       Date:  1991-01-05       Impact factor: 5.469

6.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

7.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

Review 8.  Properties of human malignant glioma cells in vitro.

Authors:  J Pontén; B Westermark
Journal:  Med Biol       Date:  1978-08

9.  Expression of tyrosine hydroxylase gene in cultured hypothalamic cells: roles of protein kinase A and C.

Authors:  W Kedzierski; N Aguila-Mansilla; G P Kozlowski; J C Porter
Journal:  J Neurochem       Date:  1994-02       Impact factor: 5.372

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  2 in total

Review 1.  The 14-3-3 proteins: gene, gene expression, and function.

Authors:  Yasuo Takahashi
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

2.  Increases in expression of 14-3-3 eta and 14-3-3 zeta transcripts during neuroprotection induced by delta9-tetrahydrocannabinol in AF5 cells.

Authors:  Jia Chen; Chun-Ting Lee; Stacie L Errico; Kevin G Becker; William J Freed
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.